Sinovation Medical logo

Sinovation Medical

Sinovation Medical, based in Beijing, makes neurosurgical robots, neuronavigation systems, a laser ablation system, and intracranial electrodes. It had revenue of 188.7 million yuan in 2025, about 26 million dollars.1,2,6

Robotics Reviewed Editorial TeamUpdated November 10, 2026sinovationmed.com

Our take

Sinovation sells a full set of tools for brain surgery: the SR1 neurosurgical robot, sold abroad as Sinobot X1, the Q300 miniature robot, the X1000 brain and spine robot, a navigation system, an MR-guided laser ablation system, and intracranial electrodes.1,2,3

It suits Chinese hospitals that treat epilepsy, brain tumors, and brain bleeds and want robot, navigation, and electrodes from one supplier. Sinovation does not publish prices; its STAR Market prospectus shows an average price of about 913,000 yuan per navigation and positioning system in 2025.2,7

Scores by criterion

Sinovation Medical scores out of 10
Pricing transparency3.5
Product maturity7.5
Deployment evidence7.0
Company durability6.5
Ease of integration6.5
Overall score (average of the five)6.2

Pricing transparency, 3.5: Sinovation lists no prices. Its prospectus discloses average selling prices, about 913,000 yuan per navigation and positioning system and 1.17 million yuan per laser ablation system in 2025.1,7

Product maturity, 7.5: The SR1 robot was approved in China in 2018, the Q300 in 2022, and the X1000 brain and spine robot in 2024. Sinovation holds 12 Class III device registrations, and its 3D structured light robot was cleared by the FDA in 2023.2

Deployment evidence, 7.0: Sinovation reports its products in more than 400 hospitals in 34 provincial regions and more than 50,000 patients treated. It sold 72 navigation and positioning systems, a group that includes its robots, in 2025.2,7

Company durability, 6.5: Revenue was 188.7 million yuan in 2025, up 30 percent, with net profit of 40.5 million yuan. Profit before one-off items was 21.5 million yuan, and press coverage of the prospectus notes that government grants support its earnings.6,7

Ease of integration, 6.5: Its robots register patients without markers using existing CT and MRI images, in about 30 seconds for the Sinobot X1, and the product range covers planning, surgery, and monitoring. Sinovation publishes little on links to other hospital systems.3,4,2

Each criterion is defined on our methodology page.

Who uses Sinovation and what it's for

The buyer is a hospital neurosurgery department that does stereotactic work such as biopsies, hematoma drainage, electrode placement for epilepsy, and laser ablation.4,5

Buyers should compare it with Remebot, Zimmer Biomet ROSA ONE Brain, Globus ExcelsiusGPS, and Renishaw neuromate.

Robots, navigation, and laser ablation

The Sinobot X1 uses Holoshot 3D structured light to scan the patient's whole head and register it without markers, with average registration accuracy of 0.5 millimeters.3

The Q300 miniature robot combines navigation and frameless stereotaxis, registers in under a minute from existing CT and MRI images, and guides biopsy needles, drainage tubes, and electrodes with sub-millimeter accuracy.4

The LS1 laser ablation system, the first of its type approved in China, places a laser fiber into a brain lesion and heats it under live MRI monitoring.5

Deployments and sales

Sinovation says its neurosurgical robots overtook imported products in China in 2020 and that cumulative surgeries passed 10,000 in 2021.2

In 2025 intracranial electrodes made up 46.9 percent of revenue, navigation and positioning systems 34.9 percent, and laser ablation 13.8 percent.7

Pricing

Sinovation does not publish prices. Average selling prices of navigation and positioning systems were about 1.24 million yuan in 2023, 813,000 yuan in 2024, and 913,000 yuan in 2025, falling in 2024 as more of the lower-priced Q300 robots were sold.7

Company, leadership, and revenue

Sinovation was set up in 2015; its electrode subsidiary HKHS dates from 2005. It filed for a listing on the Shanghai STAR Market, accepted on June 30, 2026.2,7

Revenue was 147.5 million yuan in 2023, 144.7 million in 2024, and 188.7 million in 2025.6

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprisesNot yet reviewed45678910Review Score← Smaller operationsLarge enterprises →Who it's built for6.25.67.26.8
Sinovation Medical and its competitors
CompanyProductPricing modelDeployment footprintWhere Sinovation wins or loses
Sinovation MedicalSR1, Q300, and X1000 robots plus navigation and laser ablation2Not published; about 913,000 yuan average per system in 20257More than 400 hospitals in China2Robots, navigation, ablation, and electrodes; prices not published; private, IPO filed
RemebotNeurosurgical robots and a semi-active dental implant robot8,17Not published8More than 400 hospitals in China; 52 neurosurgical robots sold in 20258,9Remebot wins on a range that runs from large to smaller hospitals. Sinovation wins on a full brain-surgery range from one supplier.
Zimmer Biomet ROSA ONE BrainRobot built for stereotactic neurosurgery11Not published; quote11U.S. hospital systems such as RWJBarnabas10ROSA ONE Brain wins on a robot designed for neurosurgery and U.S. clearance. Sinovation wins on a full brain-surgery range from one supplier.
Globus Medical ExcelsiusGPSRigid arm plus full navigation, CT or fluoroscopy15Quote; spec sheet by request15141.0 million dollars of enabling technology sales in 202514ExcelsiusGPS wins on one robot for spine and cranial work. Sinovation wins on a full brain-surgery range from one supplier.
Renishaw neuromateStereotactic robot, frame-based or frameless16Not published; contact sales16Used by teams such as London Health Sciences Centre16neuromate wins on frame or frameless stereotaxy. Sinovation wins on a full brain-surgery range from one supplier.

Limits

No published prices.1

Earnings lean on government grants.7

Most sales are in China.2

What customers say

Where it helps

Robot, navigation, laser ablation, and electrodes from one supplier.2

Where it falls short

Prices only through sales.1

Leadership

Sinovation does not publish leadership photos. Wang Ke, a clinical medicine graduate of Beijing Medical University, founded HKHS in 2005 and Sinovation in 2015, is chairman and, since March 2024, general manager, and controls 58.17 percent of the voting rights.6

    Sources

    1. Sinovation, homepage, accessed November 10, 2026
    2. Sinovation, About and company history, accessed November 10, 2026
    3. Sinovation, Sinobot X1 neurosurgical robot (SR1 series), accessed November 10, 2026
    4. Sinovation, Q300 miniature neurosurgical robot, accessed November 10, 2026
    5. Sinovation, MR-guided laser interstitial thermal therapy system, accessed November 10, 2026
    6. Sina Tech, Sinovation files for STAR Market listing, 2025 revenue 189 million yuan (July 3, 2026), accessed November 10, 2026
    7. Sina Finance, Sinovation prospectus: revenue mix, unit sales and prices (August 31, 2026), accessed November 10, 2026
    8. China Medical and Surgical Robotics Database, Remebot, accessed November 4, 2026
    9. MedChina, 2025 China Surgical Robot Sales Annual Report, accessed November 4, 2026
    10. RWJBarnabas Health, ROSA robotic technology for minimally invasive brain surgery, accessed November 10, 2026
    11. Zimmer Biomet, ROSA ONE Brain: Robotic Neurosurgery, accessed November 10, 2026
    12. U.S. FDA, 510(k) K214065, ROSA ONE Brain application, accessed November 10, 2026
    13. Zimmer Biomet, Fourth Quarter and Full-Year 2025 Financial Results (February 10, 2026), accessed November 10, 2026
    14. Globus Medical, fourth quarter and full year 2025 results, SEC Form 8-K exhibit 99.1, accessed November 9, 2026
    15. Globus Medical, ExcelsiusGPS product page, accessed November 9, 2026
    16. Renishaw, neuromate stereotactic robot for neurosurgery, accessed November 10, 2026
    17. China Medical and Surgical Robotics Database, Remebot Dental Robot, accessed November 3, 2026